ProMIS appoints new chief commercial officer to prepare Alzheimer’s drug PMN310 for market
Longevity.Technology · 19d ago
Untick a publication to hide it. Your choices stay in this browser. Journals, preprints, consumer brands and other high-volume feeds are off until you turn them on.
Medicine & Biotech · covered by 1 outlet this week · tracked since 2026-10-27
Press: 1 specialist outlet-days